Tumour stemness and poor clinical outcomes in haemochromatosis patients with hepatocellular carcinoma.

This study demonstrates that the clinical course of patients with HFE-HCC is more aggressive and provides the first data indicating that their tumours have increased expression of progenitor markers. These findings suggest patients with HFE-HCC may need to be considered for transplant at an earlier stage.